Donepezil, galantamine, rivastigmine and memantine for the treatment of Alzheimer's disease

Technology appraisal guidance
Reference number: TA217
Published: 23 March 2011
Last updated: 20 June 2018

Download guidance (PDF)

7 Related NICE guidance

Dementia: assessment, management and support for people living with dementia and their carer (2018) NICE guideline NG97